Task: Answer the multiple-choice question.
Question: Which compound exhibits a 0.005\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cn1c(N)c(C(=O)COC(=O)Cc2ccsc2)c(=O)n(C)c1=O
b.) CC(=O)Nc1ccc(NC(=S)NC(=O)/C=C/c2ccccc2)cc1
c.) Cn1c(=O)c2nc(NCc3ccccc3)cnc2n(C)c1=O
Answer: a. Cn1c(N)c(C(=O)COC(=O)Cc2ccsc2)c(=O)n(C)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] 2-thiophen-3-ylacetate